ArsenalBio's CEO & Co-Founder Ken Drazan, MD, participated in a panel at the Health Technology Innovation Policy Conference in Washington, DC today. The panel brought together leading experts from companies, venture capital, the patient advocacy community, and FDA to discuss current policy challenges impacting #biotechnology #innovation. #thoughtleadership #celltherapy
How are recent policy changes impacting investment and innovation in the biotechnology ecosystem? What are the implications for patient access? Don’t miss the chance to hear from leading experts — Jeff Allen, Peter Kolchinsky, Ken Drazan, Emil Kakkis, Peter Marks, and D. Michael Ackermann — as they tackle this critical subject at the Stanford Biodesign Health Technology Innovation Policy Conference on May 8. You still have time to register! Link in comments. #biotech #healthtech #healthpolicy